Sight Sciences wins damages against Alcon

Sight Sciences has secured a favorable outcome on post-trial motions, preserving a jury's verdict that awards significant monetary damages against Alcon. The court upheld the jury's finding of willful infringement by Alcon, leading to an award exceeding $34 million in past damages, along with ongoing royalties. This legal victory strengthens Sight Sciences' position in the ophthalmic device market, particularly concerning its microstent technology. The decision highlights the importance of intellectual property rights and successful litigation in protecting innovation within the healthcare sector.